Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Emerging Therapy
Page 3
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Aravax Testing New Way to Tackle Food Allergy
News Wire ~ 3rd Party Press Release
-
2024/11/15
Are Biologics the Future of Food Allergy Treatment? One Study Weighs Pros and Cons
Aquestive Announces Positive Topline Results from Study of Sublingual Epinephrine Film on OAS
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
New Phase 1 Study in Peanut Allergy Recruiting Now in Australia
Nanoparticle Prevented Anaphylaxis Without Side Effects in Mouse Study
Dave Bloom
-
2024/01/25
0
Promising Food Allergy Treatment from Aravax Receives $12 Million Investment
Dave Bloom
-
2024/01/23
0
Update On Neffy, the Epinephrine Nasal Spray from ARS Pharma
Dave Bloom
-
2024/01/22
0
Gut Bacteria and Metabolite Can Help Prevent Food Allergies and Other...
Dave Bloom
-
2024/01/19
0
FDA Grants Xolair Priority Review for Children and Adults with...
News Wire ~ 3rd Party Press Release
-
2023/12/19
0
Study Shows Bryn’s Epinephrine Nasal Spray Absorbed as Fast and Lasted...
Dave Bloom
-
2023/12/15
0
FDA Fast Tracks Alladapt’s ADP101 for the Treatment of Single and...
News Wire ~ 3rd Party Press Release
-
2023/11/22
0
DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler...
News Wire ~ 3rd Party Press Release
-
2023/11/10
0
Alladapt’s Multi-Allergen OIT Candidate Shows Promise in Clinical Study
News Wire ~ 3rd Party Press Release
-
2023/11/10
0
Study: Specialized Toothpaste May Lower Risk of Reactions in Adults with...
News Wire ~ 3rd Party Press Release
-
2023/11/09
0
1
2
3
4
...
27
Page 3 of 27